Shopping Cart
Remove All
Your shopping cart is currently empty
Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $122 | In Stock | In Stock | |
| 5 mg | $372 | In Stock | In Stock | |
| 10 mg | $597 | - | In Stock | |
| 25 mg | $935 | - | In Stock | |
| 50 mg | $1,260 | - | In Stock | |
| 100 mg | $1,690 | - | In Stock |
| Description | Serplulimab (HLX 10) is a humanized monoclonal anti-antibody to PD-1. Serplulimab has antitumor activity and can be used in small cell lung cancer and esophageal squamous cell carcinoma. |
| Synonyms | HLX 10 |
| Reactivity | Human |
| Verified Activity | Immobilized human PD-1-His at 2 μg/mL (30 μL/well) can bind Serplulimab with the EC50 of 12.75 ng/mL. |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | 145.06 kDa |
| Cas No. | 2231029-82-4 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.